Cytodyn Inc (CYDY)

[DonDonDonDon]

" blow the doors off "--certainly looks that way. HGEN trial was to end in SEPT--now end by APR. Originally 238 patients, had to increase to over 500 patients. Still having trouble filling trial which originally had 28 day mortality (had to change that PE) all the while with numerous sites in US and several in Brazil

HGEN followed the advice of the DSMC. Janet Woodcock has stated that trials of less than 400 patients aren't powered enough to show statistical significance. HGEN's Cameron Durrant has brought 25 drugs to market, 5 or 6 of which are blockbuster drugs. HGEN is run by experts. CYDY is run incompetently. Clearly, CYDY should have also listened to their DSMC.

Lenzilumab is GM-CSF inhibitor..
According to Dr Patterson observation of many hundreds of patients with COVID , about 20-30% have high GM-CSF.

And the UK study concluded that the patients who have elevated GM-CSF are the ones who progress to severe Covid and death. The 70%-80% who don't have high GM-CSF will be fine on their own.